USP Comment Letter: Submitted to Congress on Request for Information Regarding the Food and Drug Administration Regulation of Cannabidiol (Cannabis) Products (2023)

Submitted August 18, 2023 to Senators Sanders and Cassidy and Representatives McMorris-Rodgers and Pallone regarding the Request for Information Regarding the Food and Drug Administration Regulation of Cannabidiol Products.